Home
About
Overview
Sharing Data
ORCID
Help
History (17)
AJRCCM: 100-Year Anniversary. Progress in Interstitial Lung Disease.
RNAi screen identifies UBE2D3 as a mediator of all-trans retinoic acid-induced cell growth arrest in human acute promyelocytic NB4 cells.
Bypassing Phase Variation of Lipooligosaccharide (LOS): Using Heptose 1 Glycan Mutants To Establish Widespread Efficacy of Gonococcal Anti-LOS Monoclonal Antibody 2C7.
Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study.
Gene therapy in metachromatic leukodystrophy.
See All 17 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Gene therapy in metachromatic leukodystrophy.
Sevin C, Cartier-Lacave N, Aubourg P. Gene therapy in metachromatic leukodystrophy. Int J Clin Pharmacol Ther. 2009; 47 Suppl 1:S128-31.
View in:
PubMed
subject areas
Animals
Brain
Cerebroside-Sulfatase
Disease Models, Animal
Genetic Therapy
Hematopoietic Stem Cell Transplantation
Humans
Leukodystrophy, Metachromatic
Microinjections
authors with profiles
Nathalie Cartier-Lacave MD